Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): Characterization of conjugation products by ESI-MSn and theoretical calculations
-
Add time:08/12/2019 Source:sciencedirect.com
Acrolein (ACR) is a well-known carbonyl toxin produced by lipid peroxidation of polyunsaturated fatty acids, which is involved in several life-threatening pathologies such as Alzheimer disease, arteriosclerosis, diabetes, and nephropathy.The aim of this work was to study the quenching ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK), a liver cell growth factor isolated from human plasma, towards the electrophilic aldehyde ACR and to characterize the reaction products by electrospray mass spectrometry (ESI-MS/MS infusion experiments; positive ion mode). The reaction of ACR (30 μM) with GHK (0.1, 0.25, 0.5, 1.0 mM) was followed by measuring aldehyde consumption by reverse-phase HPLC (phosphate buffer, pH 7.4); after 4 h, when the aldehyde had completely disappeared; the reaction products were checked by ESI-MS/MS. Several products were detected in the GHK + ACR reaction (1:1). This indicates a complex reaction cascade involving the sequential addition of ACR (up to 3 mol) to the tripeptide GHK and, in particular, to the ɛ-amino group of the lysine residue and to the Nτ and Nπ of the histidine moiety. The Michael addition of two molecules of ACR to the ɛ-amino group of the lysine residue is followed by aldol condensation and dehydration to give the N-(3-formyl-3,4-dehydropiperidino) derivative.The results confirm that the ESI-MS/MS approach in a direct infusion experiment permits rapid profiling of the products of the GHK + ACR reaction. They firstly point to the potential medicinal use of GHK in the prevention of carbonyl stress-linked pathologies, and – second – help shed light on the physiological role of this histidine-containing tripeptide which is claimed to be an endogenous growth factor, but has never been shown to be an ACR quencher.
We also recommend Trading Suppliers and Manufacturers of 4-(glycyl-histidyl-lysine)-1-hydroxyanthraquinone (cas 132391-60-7). Pls Click Website Link as below: cas 132391-60-7 suppliers
Prev:Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity
Next:Expression and Activation of Matrix Metalloproteinases in Wounds: Modulation by the Tripeptide–Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effectiveness of polyamidoamine dendrimers modified with tripeptide growth factor, glycyl-l08/18/2019
- Simultaneous determination of glycyl–l08/17/2019
- Glycyl-histidyl-lysine interacts with the angiotensin II AT1 receptor08/16/2019
- Expression of Glycosaminoglycans and Small Proteoglycans in Wounds: Modulation by the Tripeptide–Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+08/15/2019
- Binding of the growth factor glycyl-l08/14/2019
- Expression and Activation of Matrix Metalloproteinases in Wounds: Modulation by the Tripeptide–Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+08/13/2019
- Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity08/11/2019
- Formation equilibria of nickel complexes with glycyl-histidyl-lysine and two synthetic analogues08/10/2019
- ESI-MS study of the mechanism of glycyl-l08/09/2019


